Luka!
@cruciblethree.bsky.social
Queer, author, bartender/mixologist, MtG deck doctor. Inquire within!
Some great new reaction images to use when people are obtuse on BlueSky.
what the fuck why does this @stupidtwink.bsky.social comic keep happening?
Jez San, founder of Argonaut, donated 2 million pounds to the conservative party in 2025. He was the biggest individual donor in Q1 of that year. Please, be informed before purchasing anything. You can emulate PS1 games on basically any device these days (even your phone) with ease.
WELL NOW, would you look at that? A massive, 24-YEAR-LONG study of MORE THAN 1.2 MILLION people in Denmark found NO LINK between aluminum in childhood vaccines and autism, asthma, OR chronic disorders. Aluminum is an ADJUVANT. It ENHANCES your immune response to a vaccine. That’s it.
QRP with your most popular piece on bsky - Apparently it was this one
QRP with your most popular piece on bsky - My D&D characters from 1995 to 2023 on a single page! Those I played for more than a few sessions at least.
Just because June is over doesn't mean you don't need these gay stickers! crippledgiraffdecals.bigcartel.com/product/gay-...
this one is rad too. i really need to get some prints of his works in my apartment
Probably my favourite piece by Don Ivan Punchatz, the dude who painted the box art for the original DooM
beyond stoked to announce that THE ARRANGEMENT, a 32 page body horror comic about gender & surrogacy, created by myself and @valhal.bsky.social will be serialized in @boom-studios.com HELLO DARKNESS, starting in October with HELLO DARKNESS 26
Wedding in the Photographer’s Studio (1879) - Pascal Dagnan-Bouveret (1852–1929) #naturalism #domestic_ritual
GOOD NEWS! Phase I clinical trial results out of WashU Medicine show a first-of-its-kind personalized DNA vaccine designed to treat MGMT-unmethylated glioblastoma is safe AND elicits robust and broad immune responses that appears to INCREASE recurrence-free survival in patients after surgery.
Personalized DNA Vaccine Shows Immune Activation and Survival Signals in Glioblastoma Trial
Personalized neoantigen vaccine triggered immune responses and promising survival outcomes in MGMT-unmethylated glioblastoma Phase I trial patients.
insideprecisionmedicine.com